Ekaterina Pestova
Overview
Explore the profile of Ekaterina Pestova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lassman A, Roberts-Rapp L, Sokolova I, Song M, Pestova E, Kular R, et al.
Clin Cancer Res
. 2019 Feb;
25(11):3259-3265.
PMID: 30796037
Purpose: Patients with glioblastoma (GBM) have a poor prognosis and are in desperate need of better therapies. As therapeutic decisions are increasingly guided by biomarkers, and EGFR abnormalities are common...
2.
Lim S, Chang H, Cha Y, Liang S, Tai Y, Li G, et al.
Lung Cancer
. 2017 Aug;
111:79-83.
PMID: 28838404
Background: ALK and ROS1 gene rearrangements are distinct molecular subsets of non-small-cell lung cancer (NSCLC), and they are strong predictive biomarkers of response to ALK/ROS1 inhibitors, such as crizotinib. Thus,...
3.
Wang J, Goetsch L, Tucker L, Zhang Q, Gonzalez A, Vaidya K, et al.
BMC Cancer
. 2016 Feb;
16:105.
PMID: 26879245
Background: c-Met is the receptor tyrosine kinase for hepatocyte growth factor (HGF) encoded by the MET proto-oncogene. Aberrant activation of c-Met resulting from MET amplification and c-Met overexpression is associated...
4.
Heselmeyer-Haddad K, Berroa Garcia L, Bradley A, Hernandez L, Hu Y, Habermann J, et al.
Am J Pathol
. 2014 Aug;
184(10):2671-86.
PMID: 25131421
Gauging the risk of developing progressive disease is a major challenge in prostate cancer patient management. We used genetic markers to understand genomic alteration dynamics during disease progression. By using...
5.
Graham R, Barr Fritcher E, Pestova E, Schulz J, Sitailo L, Vasmatzis G, et al.
Hum Pathol
. 2014 May;
45(8):1630-8.
PMID: 24837095
Patients with cholangiocarcinoma often present with locally advanced or metastatic disease. There is a need for effective therapeutic strategies for advanced stage cholangiocarcinoma. Recently, FGFR2 translocations have been identified as...
6.
Gerami P, Cooper C, Bajaj S, Wagner A, Fullen D, Busam K, et al.
Am J Surg Pathol
. 2013 Jun;
37(9):1387-94.
PMID: 23797719
Death due to melanoma in childhood (up to 20 y of age) is a rare event, with an average of 18 cases reported annually in the United States. In this...
7.
Shen L, Cooper C, Bajaj S, Liu P, Pestova E, Guitart J, et al.
Am J Dermatopathol
. 2013 Mar;
35(8):804-12.
PMID: 23455333
Determining risk assessment for aggressive behavior of atypical Spitz tumors (ASTs) remains a significant challenge for pathologists. Despite the presence of many concerning histological features such as tumor ulceration, expansile...
8.
Gerami P, Scolyer R, Xu X, Elder D, Abraham R, Fullen D, et al.
Am J Surg Pathol
. 2013 Feb;
37(5):676-84.
PMID: 23388126
Risk assessment for atypical Spitz tumors remains an enigma for physicians. Many prognosticators including sentinel lymph node biopsy fail to show the same prognostic significance in these tumors as seen...
9.
Larrabee P, Johnson K, Pestova E, Lucas M, Wilber K, Leshane E, et al.
Am J Hum Genet
. 2004 Jul;
75(3):485-91.
PMID: 15252756
Metaphase karyotype analysis of fetal cells obtained by amniocentesis or chorionic villus sampling is the current standard for prenatal cytogenetic diagnosis, particularly for the detection of trisomy 21. We previously...
10.
Pestova E, Wilber K, King W
Methods Mol Med
. 2004 Apr;
97:355-75.
PMID: 15064505
No abstract available.